Gryphon Therapeutics
San Francisco
About Gryphon Therapeutics
Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols such as molecules to create potent medications.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $26.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2002)
- Website: gryphonsci.com
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/gryphon-therapeutics-2208704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.